Form 8-K OMEROS CORP For: Jun 18
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 18, 2026
(Exact name of Registrant as Specified in Its Charter)
|
|
|
|
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant’s Telephone Number, Including Area Code: (206 ) 676-5000
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities Registered Pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
The
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 under the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 5.07
|
Submission of Matters to a Vote of Security Holders.
|
Omeros Corporation (“Omeros”) held its 2026 Annual Meeting of Shareholders on June 18, 2026 (the “Annual Meeting”). Shareholders of record at the close of business on April 17, 2026 were entitled to vote 72,168,330 shares of common stock at the Annual Meeting. A total of 58,010,900 shares (80.04%) were represented at the Annual Meeting in person or by proxy. Set forth below is a brief description of each matter voted upon at the Annual Meeting and the final voting results for each matter.
|
(1)
|
By the vote set forth below, Thomas J. Cable, Peter A. Demopulos, M.D., and Diana T. Perkinson, M.D., were elected as Class II directors, each to serve until the 2029 Annual Meeting of Shareholders, or, in each case, until his or her successor is duly elected and qualified, or until his or her earlier death, resignation or removal.
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
|
Thomas J. Cable
|
|
20,787,774 |
|
10,531,585 |
|
429,499 |
|
26,262,042 |
|
Peter A. Demopulos, M.D.
|
|
25,314,641 |
|
6,063,216 |
|
371,001 |
|
26,262,042 |
|
Diana T. Perkinson, M.D.
|
22,939,756 |
|
8,295,563 |
|
513,539 |
|
26,262,042 |
|
(2)
|
Shareholders approved an advisory resolution regarding the compensation of Omeros’ named executive officers as reported in the proxy statement for the 2026 Annual Meeting of Shareholders by the vote set forth below.
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
| 24,384,445 |
|
6,856,592 |
|
507,821 |
|
26,262,042 |
|
(3)
|
Shareholders approved the Amended and Restated Omeros Corporation Omnibus Incentive Compensation Plan by the vote set forth below.
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
| 19,116,509 |
|
12,184,390 |
|
447,959 |
|
26,262,042 |
|
(4)
|
Shareholders ratified the appointment of Ernst & Young LLP as Omeros’ independent registered public accounting firm for the fiscal year ending December 31, 2026 by the vote set forth below.
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
| 53,083,043 |
|
4,423,648 |
|
504,209 |
|
—
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
OMEROS CORPORATION
|
|
|
|
|
|
|
Date: June 25, 2026
|
By:
|
/s/ Gregory A. Demopulos
|
|
|
|
Gregory A. Demopulos, M.D.
|
|
|
|
President, Chief Executive Officer and
|
|
|
|
Chairman of the Board of Directors
|
ATTACHMENTS / EXHIBITS
XBRL TAXONOMY EXTENSION SCHEMA
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
XBRL TAXONOMY EXTENSION LABEL LINKBASE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Omeros Corp. (OMER) PT Lowered to $33 at H.C. Wainwright
- MEDIA ADVISORY - Championship Game to Crown the 37th Annual Brick Invitational Hockey Tournament Champions
- MixRoute Confirms Claude Fable 5 Support, Giving Developers One-Key Access to Both Fable 5 and GPT-5.6
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
